跳至主要内容
临床试验/IRCT2016042027506N1
IRCT2016042027506N1已完成2 期

Comparison of Donepezil and Placebo as adjunctive therapy with Ritalin on Executive Functioning of children with Attention Deficit Hyperactivity Disorder

Vice chancellor for research, Tehran University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
4 years 至 12 years(—)
性别
All

入选标准

  • 1. Age of six to twelve years; 2. DSM-5 criteria for a diagnosis of ADHD; 3. IQ above 90. Exclusion criteria: 1. an intervening physical disorder such as neurological disorders, a record of severe allergic reaction to Ritalin or Donepezil, record of heart disease; 2. a major psychiatric disease such as mood disorders, psychotic disorders, substance abuse.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Tehran University of Medical Sciences

相似试验